242 related articles for article (PubMed ID: 7792930)
21. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer D; Clarke DE; Fozard JR; Hartig PR; Martin GR; Mylecharane EJ; Saxena PR; Humphrey PP
Pharmacol Rev; 1994 Jun; 46(2):157-203. PubMed ID: 7938165
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in 5-HT1B/1D receptor antagonists and agonists and their potential therapeutic applications.
Slassi A
Curr Top Med Chem; 2002 Jun; 2(6):559-74. PubMed ID: 12052194
[TBL] [Abstract][Full Text] [Related]
23. Targeting 5-HT receptors for the treatment of obesity.
Sargent BJ; Henderson AJ
Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209
[TBL] [Abstract][Full Text] [Related]
24. Serotonin receptor subtypes: implications for psychopharmacology.
Cowen PJ
Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
[TBL] [Abstract][Full Text] [Related]
25. Behavioral pharmacology: potential antidepressant and anxiolytic properties.
Wesołowska A; Jastrzębska-Więsek M
Int Rev Neurobiol; 2011; 96():49-71. PubMed ID: 21329784
[No Abstract] [Full Text] [Related]
26. Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice.
Gleason SD; Shannon HE
Eur J Pharmacol; 1998 Jan; 341(2-3):135-8. PubMed ID: 9543230
[TBL] [Abstract][Full Text] [Related]
27. Modulation of brainstem 5-HT1C receptors by serotonergic drugs in the rat.
Pranzatelli MR; Tailor PT
Gen Pharmacol; 1994 Oct; 25(6):1279-84. PubMed ID: 7875557
[TBL] [Abstract][Full Text] [Related]
28. Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.
Nelson DL; Lucaites VL; Wainscott DB; Glennon RA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):1-6. PubMed ID: 9933142
[TBL] [Abstract][Full Text] [Related]
29. The 5-HT7 receptor: orphan found.
Eglen RM; Jasper JR; Chang DJ; Martin GR
Trends Pharmacol Sci; 1997 Apr; 18(4):104-7. PubMed ID: 9149537
[No Abstract] [Full Text] [Related]
30. The role of serotonin receptors in the action of atypical antipsychotic drugs.
Meltzer HY; Massey BW
Curr Opin Pharmacol; 2011 Feb; 11(1):59-67. PubMed ID: 21420906
[TBL] [Abstract][Full Text] [Related]
31. 5-ht6 receptors.
Woolley ML; Marsden CA; Fone KC
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):59-79. PubMed ID: 14965245
[TBL] [Abstract][Full Text] [Related]
32. 5-HT7 receptors.
Thomas DR; Hagan JJ
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):81-90. PubMed ID: 14965246
[TBL] [Abstract][Full Text] [Related]
33. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
[TBL] [Abstract][Full Text] [Related]
34. Emerging opportunities and concerns for drug discovery at serotonin 5-HT2B receptors.
Brea J; Castro-Palomino J; Yeste S; Cubero E; Párraga A; Domínguez E; Loza MI
Curr Top Med Chem; 2010; 10(5):493-503. PubMed ID: 20166944
[TBL] [Abstract][Full Text] [Related]
35. Ligands for the investigation of 5-HT autoreceptor function.
Roberts C; Price GW; Middlemiss DN
Brain Res Bull; 2001 Nov; 56(5):463-9. PubMed ID: 11750791
[TBL] [Abstract][Full Text] [Related]
36. Messenger RNA editing of the human serotonin 5-HT2C receptor.
Fitzgerald LW; Iyer G; Conklin DS; Krause CM; Marshall A; Patterson JP; Tran DP; Jonak GJ; Hartig PR
Neuropsychopharmacology; 1999 Aug; 21(2 Suppl):82S-90S. PubMed ID: 10432493
[TBL] [Abstract][Full Text] [Related]
37. 5-Hydroxytryptamine-receptor subtypes.
Brodde OE
Clin Physiol Biochem; 1990; 8 Suppl 3():19-27. PubMed ID: 2132174
[TBL] [Abstract][Full Text] [Related]
38. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
[TBL] [Abstract][Full Text] [Related]
39. Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment.
Hietala J; Kuonnamäki M; Pälvimäki EP; Laakso A; Majasuo H; Syvälahti E
Psychopharmacology (Berl); 2001 Sep; 157(2):180-7. PubMed ID: 11594443
[TBL] [Abstract][Full Text] [Related]
40. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications].
Moulignier A
Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
